What did TowerBrook / Ascension pay for Hospice Compassus?

TowerBrook / Ascension acquired Hospice Compassus for $1.05B in 2019 (13.1x EBITDA), equivalent to 2.20x revenue. Target revenue was approximately $480.0M. Target EBITDA was approximately $80.0M.

What does Hospice Compassus do?

Hospice Compassus is a hospice business.

What multiple did TowerBrook / Ascension pay for Hospice Compassus?

13.1x EBITDA and 2.20x revenue, based on disclosed deal value of $1.05B and disclosed financials.

M&A TRANSACTION · 2019

Hospice Compassus acquired by TowerBrook / Ascension

$1.05B· 13.1x EBITDA· 2.20x revenue

Target

Hospice Compassus

Acquirer

TowerBrook / Ascension

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$480.0M

EBITDA

$80.0M

Deal Value

$1.05B

EV/EBITDA

13.1x

Context

This $1.05B acquisition of Hospice Compassus by TowerBrook / Ascension sits in the hospice sub-vertical. The 13.1x EBITDA multiple paid in 2019 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub. TowerBrook / Ascension is acquiring as a strategic buyer; see how strategic acquirers typically price hospice businesses on our Hospice strategic buyer-pool page.

Source

Data sourced from Bond market research and press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own hospice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Hospice Compassus acquisition.

Citation: ExitValue.ai. (2019). Hospice Compassus acquired by TowerBrook / Ascension. https://exitvalue.ai/deals/hospice-compassus-acquired-by-towerbrook-ascension-hc-2019-0140